Live feed
Filing
SC 13G
SC 13G0001104659-24-114867·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2024-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-114867
- Form type
- SC 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Nov 06, 2024
- Reporting period
- Oct 30, 2024
- Description
- Schedule 13G beneficial ownership